The Journal of Organic Chemistry
Page 12 of 23
1
2
3
4
5
6
7
8
9
7.40 (d, J = 8.0 Hz, 1H), 7.00 (t, J = 7.7 Hz, 1H), 6.89–6.81 (m, 3H), 6.81–6.75 (m, 1H), 6.72 (d, J = 8.0 Hz,
1H), 6.66–6.59 (m, 1H), 6.13 (d, J = 8.5 Hz, 1H), 3.68 (s, 3H), 2.51 (s, 3H); 13C{1H} NMR (100 MHz,
CD3OD) δ 160.6, 139.6, 134.7, 130.6, 129.8, 129.6, 128.6, 127.5, 126.0 (q, J = 295.0 Hz), 124.3, 121.2,
119.4, 118.7, 117.6, 116.3, 113.5, 113.3, 112.6, 107.0, 75.1 (q, J = 30.0 Hz), 54.4, 9.7; 19F{1H} NMR (376
MHz, CD3OD) δ -73.4. Enantiomeric excess was determined by HPLC (IA column, elute: n-Hexane/i-PrOH
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
o
= 95/5, detector: 254 nm, flow rate: 1.0 mL/min, 30 C), retention time 8.6 min (major) and 10.7 min.
HRMS (ESI-TOF) m/z Calculated for C24H20F3N2O [M+H]+ 409.1522, found 409.1533.
(+)-12-Methyl-6-(p-tolyl)-6-(trifluoromethyl)-5,6-dihydroindolo[1,2-c]quinazoline (3af). 69 mg, 88%
yield, colorless oil, new compound, Rf = 0.30 (hexanes/ethyl acetate 50:1), 92% ee, [α]20D = +54.85 (c 1.38,
EtOAc); 1H NMR (400 MHz, CD3OD) δ 7.72 (d, J = 7.8, 1H), 6.47–6.33 (m, 3H), 7.10 (d, J = 8.1 Hz, 2H),
6.97 (t, J = 7.4 Hz, 1H), 6.83 (t, J = 7.5 Hz, 1H), 6.76 (t, J = 7.5 Hz, 1H), 6.70 (d, J = 7.9 Hz, 1H), 6.57 (t, J
= 7.6 Hz, 1H) 6.09 (d, J = 8.4 Hz, 1H), 2.49 (s, 3H), 2.23 (s, 3H); 13C{1H} NMR (100 MHz, CD3OD) δ
139.7, 139.5, 134.6, 133.9, 130.6, 129.8, 128.8, 128.1, 127.5, 126.0 (q, J = 295.0 Hz), 124.3, 121.2, 119.4,
118.7, 117.6, 116.2, 113.3, 112.6, 107.0, 75.2 (q, J = 30.0 Hz), 19.8, 9.8; 19F{1H} NMR (376 MHz, CD3OD)
δ -73.2. Enantiomeric excess was determined by HPLC (IA column, elute: n-Hexane/i-PrOH = 98/2, detector:
254 nm, flow rate: 1.0 mL/min, 30 oC), retention time 7.2 min (major) and 11.0 min. HRMS (ESI-TOF) m/z
Calculated for C24H20F3N2 [M+H]+ 393.1573, found 393.1608.
(+)-12-Methyl-6-(m-tolyl)-6-(trifluoromethyl)-5,6-dihydroindolo[1,2-c]quinazoline (3ag). 67 mg, 85%
yield, white solid, m.p. = 150-151 oC, new compound, Rf = 0.30 (hexanes/ethyl acetate 50:1), 93% ee, [α]20
D
1
= +60.67 (c 1.34, EtOAc); H NMR (400 MHz, CD3OD) δ 7.73 (d, J = 7.8, 1H), 7.44–7.31 (m, 3H), 7.23–
7.11 (m, 2H), 6.97 (t, J = 7.5 Hz, 1H), 6.82 (t, J = 7.5 Hz, 1H), 6.75 (t, J = 7.6 Hz, 1H), 6.70 (d, J = 7.9 Hz,
1H), 6.58 (t, J = 7.7 Hz, 1H), 6.09 (d, J = 8.4 Hz, 1H), 2.49 (s, 3H), 2.15 (s, 3H); 13C{1H} NMR (100 MHz,
CH3OD) δ 139.5, 138.3, 136.8, 134.6, 130.6, 130.1, 129.8, 128.9, 128.0, 127.5, 126.0 (q, J = 295.0 Hz),
125.0, 124.4, 121.2, 119.5, 118.7, 117.7, 116.2, 113.3, 112.6, 107.0, 75.3 (q, J = 29.0 Hz), 20.2, 9.8; 19F{1H}
NMR (376 MHz, CH3OD) δ -73.1. Enantiomeric excess was determined by HPLC (IA column, elute: n-
Hexane/i-PrOH = 95/5, detector: 254 nm, flow rate: 1.0 mL/min, 30 oC), retention time 4.8 min (major) and
6.2 min. HRMS (ESI-TOF) m/z Calculated for C24H20F3N2 [M+H]+ 393.1573, found 393.1608.
(+)-12-Methyl-6-(naphthalen-2-yl)-6-(trifluoromethyl)-5,6-dihydroindolo[1,2-c]quinazoline (3ah). 68
mg, 79% yield, white solid, m.p. = 214-215 oC, new compound, Rf = 0.30 (hexanes /ethyl acetate 100:1), 95%
ee, [α]20D = +20.85 (c 1.18, EtOAc); 1H NMR (400 MHz, CD2Cl2) δ 8.28 (s, 1H), 7.94–7.85 (m, 2H), 7.84–
7.73 (m, 2H), 7.59–7.41 (m, 4H), 7.13–7.05 (m, 1H), 6.70–6.88 (m, 2H), 6.72–6.57 (m, 2H), 6.18 (d, J = 8.5
Hz, 1H), 4.71 (brs, 1H), 2.63 (s, 3H); 13C{1H} NMR (100 MHz, CD2Cl2) δ 138.1, 134.7, 133.6, 133.4, 132.4,
S12
ACS Paragon Plus Environment